
pmid: 3936325
handle: 2434/183650
Eighteen subfertile men, with idiopathic normogonadotropic oligozoospermia were treated with an antiestrogenic compound, tamoxifen (Nolvadex), at the dose of 20 mg/day for four months. Hormonal parameters (LH, FSH, Testosterone, Prolactin) were evaluated before treatment and after 45 and 90 days of therapy. Serum LH, FSH and Testosterone increased significantly after 45 days of tamoxifen treatment. Seminal analyses, performed before and after three months of therapy showed improvements in sperm motility and in sperm density. By our clinical findings, tamoxifen can be considered a useful approach for an empiric treatment of idiopathic oligozoospermia.
Adult, Male, Sperm Count, Oligospermia, Luteinizing Hormone, Oligospermia; Testosterone; Luteinizing Hormone; Sperm Count; Humans; Adult; Sperm Motility; Tamoxifen; Male; Follicle Stimulating Hormone, Tamoxifen, Sperm Motility, Humans, Testosterone, Follicle Stimulating Hormone
Adult, Male, Sperm Count, Oligospermia, Luteinizing Hormone, Oligospermia; Testosterone; Luteinizing Hormone; Sperm Count; Humans; Adult; Sperm Motility; Tamoxifen; Male; Follicle Stimulating Hormone, Tamoxifen, Sperm Motility, Humans, Testosterone, Follicle Stimulating Hormone
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
